Boston Scientific (BSX) FY2021 results: revenue $11.9 billion, up 19.9% on the year
Boston Scientific Corp. (BSX) reported revenue of $11.9 billion for fiscal 2021, the year ended 31 December 2021, up 19.9% on the year before. Net income was $985 million, and diluted earnings per share $0.69. The figures are the company's own, from the 10-K it filed with the SEC on 23 February 2022.
Revenue
$11.9 billion
+19.9% on the year
FY2014FY2021
Operating margin
10.1%
-0.8% a year earlier
FY2014FY2021
Net income
$985 million
FY2014FY2021
Diluted EPS
$0.69
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
1,870
1,508
1,836
+24.0%
Capital expenditure
554
376
461
+47.3%
Free cash flow
1,316
1,132
1,375
+16.3%
Free cash flow margin
11.1%
11.4%
12.8%
Cash from investing
-1,597
-411
-5,041
Cash from financing
-95.0
293
2,973
Depreciation and amortisation
1,093
1,123
1,011
-2.7%
Share-based compensation
194
170
157
+14.1%
Buybacks
0.0
535
0.0
Dividends paid
55.0
28.0
0.0
+96.4%
Diluted shares, weighted
1,434m
1,417m
1,411m
+1.2%
Shares outstanding at period end
n/a
n/a
1,395m
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
16,622
15,326
13,877
+8.5%
Debt
9,065
9,130
10,008
-0.7%
Operating lease liabilities
389
401
276
-3.0%
Other liabilities
6,153
5,920
6,404
+3.9%
Total liabilities and equity
32,229
30,777
30,565
+4.7%
Fixed assets
2,252
2,084
2,079
+8.1%
Goodwill
11,988
9,951
10,176
+20.5%
Intangible assets
6,121
5,917
7,886
+3.4%
Securities held for sale or to maturity
0.0
2.0
23.0
Cash and equivalents
1,925
1,734
217
+11.0%
Inventory
1,610
1,351
1,579
+19.2%
Other assets
8,333
9,738
8,605
-14.4%
Total assets
32,229
30,777
30,565
+4.7%
10-K for the year ended 31 December 2021, filed 23 February 2022: the filing.